Ensysce Biosciences, Inc.

ENSC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$3,502$1,124$3,148$12,265
Short-Term Investments$0$0$0$0
Receivables$124$98$277$442
Inventory$0$0$0-$442
Other Curr. Assets$1,718$1,068$1,875$3,398
Total Curr. Assets$5,345$2,289$5,299$15,663
Property Plant & Equip (Net)$0$0$0$24,721,000
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$253$419$586-$24,720,245
Total NC Assets$253$419$586$755
Other Assets$0$0$0$0
Total Assets$5,597$2,708$5,885$16,417
Liabilities
Payables$1,357$1,936$2,944$301
Short-Term Debt$302$855$4,294$12,773
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$548$542$2,226$3,408
Total Curr. Liab.$2,207$3,333$9,464$16,482
LT Debt$0$0$140$4,441
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$10$26$310$3,653
Total NC Liab.$10$26$450$8,094
Other Liabilities$0$0$0$0
Cap. Leases$0$0$27$25
Total Liabilities$2,217$3,359$9,915$24,575
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$129,544-$121,557-$110,931-$85,846
AOCI$0$0$0$0
Other Equity$133,253$121,234$107,217$77,965
Total Equity$3,708-$323-$3,714-$7,878
Supplemental Information
Minority Interest-$328-$328-$315-$280
Total Liab. & Tot. Equity$5,597$2,708$5,885$16,417
Net Debt-$3,200-$269$1,286$4,949